FDC Financial Statement Analysis
|
||
|
The Revenues of FDC have increased by 8.92% YoY .
The Earnings Per Share (EPS) of FDC has increased by 60.26 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
FDC Last 5 Annual Financial Results
[BOM: 531599|NSE : FDC]
| Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr | ₹1,344 Cr |
| Expenses | ₹1,604 Cr | ₹1,534 Cr | ₹1,274 Cr | ₹999 Cr | ₹1,051 Cr |
| Operating Profit (Excl OI) | ₹339 Cr | ₹250 Cr | ₹254 Cr | ₹334 Cr | ₹293 Cr |
| Other Income | ₹102 Cr | ₹51 Cr | ₹76 Cr | ₹97 Cr | ₹69 Cr |
| Interest | ₹4.03 Cr | ₹4.09 Cr | ₹3.09 Cr | ₹3.43 Cr | ₹3.42 Cr |
| Depreciation | ₹40 Cr | ₹39 Cr | ₹37 Cr | ₹38 Cr | ₹37 Cr |
| Profit Before Tax | ₹396 Cr | ₹258 Cr | ₹289 Cr | ₹388 Cr | ₹320 Cr |
| Profit After Tax | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr |
| Consolidated Net Profit | ₹305 Cr | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr |
| Earnings Per Share (Rs) | ₹18.75 | ₹11.70 | ₹12.82 | ₹17.85 | ₹14.03 |
| PAT Margin (%) | 15.26 | 10.54 | 13.74 | 22.06 | 17.40 |
| ROE(%) | 14.96 | 9.84 | 11.71 | 18.36 | 16.03 |
| ROCE(%) | 19.62 | 13.27 | 15.78 | 23.74 | 21.56 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 6,849.0 Cr |
| Revenue (TTM) | : | ₹ 2,078.3 Cr |
| Net Profit(TTM) | : | ₹ 274.4 Cr |
| EPS (TTM) | : | ₹ 16.9 |
| P/E (TTM) | : | 25.0 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FDC | -3.5% | 2.8% | -6% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.9% | 2.2% | 23.9% |
| DIVIS LABORATORIES | 3.3% | 4.7% | 58% |
| CIPLA | 0.5% | 2% | 11.1% |
| TORRENT PHARMACEUTICALS | -0.4% | 2.8% | 24.2% |
| DR REDDYS LABORATORIES | -0.8% | -0.4% | 0.8% |
| MANKIND PHARMA | 0.5% | 6.6% | 6.6% |
| ZYDUS LIFESCIENCES | 2.3% | -2.2% | -5.1% |
| LUPIN | -1% | -0.1% | 33.4% |
FDC Revenues
[BOM: 531599|NSE : FDC]
| Y-o-Y | 8.92 % |
| 5 Yr CAGR | 9.65 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | -0.82 | |
| Mar2020 | ₹1,344 Cr | - | |
FDC Operating Profit
[BOM: 531599|NSE : FDC]
| Y-o-Y | 35.64 % |
| 5 Yr CAGR | 3.68 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹339 Cr | 35.64 | |
| Mar2023 | ₹250 Cr | -1.61 | |
| Mar2022 | ₹254 Cr | -24.06 | |
| Mar2021 | ₹334 Cr | 14.03 | |
| Mar2020 | ₹293 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 24.52 % |
| 5 Yr CAGR | -5.44 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 17.42% | 24.52 | |
| Mar2023 | 13.99% | -15.72 | |
| Mar2022 | 16.6% | -33.76 | |
| Mar2021 | 25.06% | 15.01 | |
| Mar2020 | 21.79% | - | |
FDC Profit After Tax
[BOM: 531599|NSE : FDC]
| Y-o-Y | 57.30 % |
| 5 Yr CAGR | 6.21 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹305 Cr | 57.30 | |
| Mar2023 | ₹194 Cr | -10.33 | |
| Mar2022 | ₹216 Cr | -28.19 | |
| Mar2021 | ₹301 Cr | 25.62 | |
| Mar2020 | ₹240 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 44.78 % |
| 5 Yr CAGR | -3.23 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 15.26 % | 44.78 | |
| Mar2023 | 10.54 % | -23.29 | |
| Mar2022 | 13.74 % | -37.72 | |
| Mar2021 | 22.06 % | 26.78 | |
| Mar2020 | 17.4 % | - | |
FDC Earnings Per Share (EPS)
[BOM: 531599|NSE : FDC]
| Y-o-Y | 60.26 % |
| 5 Yr CAGR | 7.52 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹19 | 60.26 | |
| Mar2023 | ₹12 | -8.74 | |
| Mar2022 | ₹13 | -28.18 | |
| Mar2021 | ₹18 | 27.23 | |
| Mar2020 | ₹14 | - | |
FDC Return on Capital Employed (ROCE)
[BOM: 531599|NSE : FDC]
| Y-o-Y | 47.85 % |
| 5 Yr CAGR | -2.33 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 19.62% | 47.85 | |
| Mar2023 | 13.27% | -15.91 | |
| Mar2022 | 15.78% | -33.53 | |
| Mar2021 | 23.74% | 10.11 | |
| Mar2020 | 21.56% | - | |
FDC Share Price vs Sensex
| Current Share Price | : | ₹420.7 |
| Current MarketCap | : | ₹ 6,849.0 Cr |
| Updated EOD on | : | Apr 29,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | -3.5% |
2.8% |
-6% |
| SENSEX | 0.9% |
3% |
8.9% |
FDC related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE 500 | 0.2% | 2.6% | 6.7% |
| BSE HEALTHCARE | -0.2% | -0.2% | 22.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY TOTAL MARKET | 0% | 2.5% | 7% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -0.4% | 2.5% | NA |
| NIFTY 500 EQUAL WEIGHT | -1.1% | 1.6% | NA |
| NIFTY MICROCAP 250 | -2.4% | -1% | 3.8% |
You may also like the below Video Courses
FAQ about FDC Financials
How the annual revenues of FDC have changed ?
The Revenues of FDC have increased by 8.92% YoY .
How the Earnings per Share (EPS) of FDC have changed?
The Earnings Per Share (EPS) of FDC has increased by 60.26 % YoY .
Check out Intrinsic Value of Peers of FDC
Compare Stock Analytics of Peers of FDC
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
